Incyte Corporation (BMV:INCY)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
JAKAFI Revenue	2.99B	2.79B	Log In	Log In	Log In	Upgrade
OPZELURA Revenue	584.08M	508.29M	Log In	Log In	Log In	Upgrade
ICLUSIG Revenue	119.39M	114.32M	Log In	Log In	Log In	Upgrade
PEMAZYRE Revenue	84.44M	81.75M	Log In	Log In	Log In	Upgrade
MINJUVI Revenue	124.93M	119.24M	Log In	Log In	Log In	Upgrade
ZYNYZ Revenue	14.00M	3.19M	Log In	Log In	Log In	Upgrade
Total Product Revenue	3.96B	3.62B	Log In	Log In	Log In	Upgrade
JAKAVI Product Royalty Revenue	431.79M	418.84M	Log In	Log In	Log In	Upgrade
OLUMIANT Product Royalty Revenue	137.56M	135.57M	Log In	Log In	Log In	Upgrade
TABRECTA Product Royalty Revenue	25.26M	22.75M	Log In	Log In	Log In	Upgrade
Other Product Royalty Revenue	3.30M	2.17M	Log In	Log In	Log In	Upgrade
Total Product Royalty Revenue	597.91M	579.33M	Log In	Log In	Log In	Upgrade
Milestone and Contract Revenue	-	43.00M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-14.00M	-3.19M	Log In	Log In	Log In	Upgrade
Revenue (Total)	4.56B	4.24B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.